PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage...
-
Upload
camron-hart -
Category
Documents
-
view
216 -
download
0
Transcript of PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage...
![Page 1: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/1.jpg)
PRESENTATION II NAME
By Christine Harvey
Dihydrofolate Reductase Beta lactmasep300Macrophage Infectivity Potentiator
![Page 2: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/2.jpg)
Dihydrofolate Reductase
in Escherichia coli
![Page 3: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/3.jpg)
http://en.wikipedia.org/wiki/DHFR
• Class: oxidoreductase
• Reduces dihydrofolate (DHF) to tetrahydrofolate (THF)
• THF is a precursor to amino acids, purine and thymidylate.
• DHFR is imperative to cell life
![Page 4: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/4.jpg)
Function
Source: Schweitzer, Barry I., et al. The FASEB Journal Vol 4, “Dihydrofolate reductase as a therapeutic target.” May 1990.
![Page 5: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/5.jpg)
Mechanism
http://en.wikipedia.org/wiki/DHFR
![Page 6: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/6.jpg)
Structure
![Page 7: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/7.jpg)
Binding Pocket
![Page 8: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/8.jpg)
![Page 10: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/10.jpg)
![Page 11: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/11.jpg)
![Page 12: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/12.jpg)
![Page 13: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/13.jpg)
![Page 14: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/14.jpg)
Sequence Alignment
![Page 15: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/15.jpg)
Phylogenetic Tree
![Page 16: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/16.jpg)
Beta-Lactamasein Escherichia coli
![Page 17: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/17.jpg)
• Class: Hydrolase
• Beta Lactamase is produce by bacteria after being exposed to beta lactam antibiotics
• Responsible for beta lactam antibiotic resistance
![Page 18: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/18.jpg)
Penicillin
• Contains beta lactam ring
![Page 19: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/19.jpg)
Mechanism
![Page 20: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/20.jpg)
![Page 21: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/21.jpg)
21
![Page 22: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/22.jpg)
![Page 23: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/23.jpg)
![Page 24: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/24.jpg)
![Page 25: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/25.jpg)
![Page 26: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/26.jpg)
![Page 27: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/27.jpg)
![Page 28: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/28.jpg)
p300In Homo Sapiens
![Page 29: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/29.jpg)
• Class: Transferase
• p300 transfers an acetyl group from acetyl coenzyme A to an active site lysine
• Transcriptional activation occurs upon acetyl transfer
![Page 30: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/30.jpg)
Title
• p300 is responsible for cell growth before and after birth
• Cancer suppressor
![Page 31: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/31.jpg)
Domains
Taz2
KIX
Bromodomain
HAT
Zinc Fingers (3)
Taz2
Creb
![Page 32: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/32.jpg)
Histone Acetyl Transferase
• Active site tyrosine acts as nucleophile
Source: http://www.bmolchem.wisc.edu/labs/denu/images/hats/sequential.jpg
![Page 33: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/33.jpg)
![Page 34: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/34.jpg)
![Page 35: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/35.jpg)
![Page 36: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/36.jpg)
![Page 37: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/37.jpg)
Docking
![Page 38: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/38.jpg)
![Page 39: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/39.jpg)
39
![Page 40: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/40.jpg)
Macrophage Infectivity Potentiator
in Legionella pneumophila
![Page 41: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/41.jpg)
Legionella pneumophila
• gram negative bacteria
• Causes Legionnaires’ disease
• Carried in aerosols from man-made water systems
![Page 42: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/42.jpg)
MIP
• Class: Isomerase
• Catalyzes the isomeration of the N-terminal on proline
• Cause of virulence in Legionnaires’ disease
• Located on outer membrane protein
• 25 kDa
![Page 43: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/43.jpg)
Crystalization
• Solution: 100 mM MES (pH 6.1–6.5), 15–20% (w/v) PEG 8000 and 500 mM zinc acetate. Protein concentration was 10 mg ml–1in 20 mM HEPES, pH 7.0
• Crystals were grown for 2-3 weeks at 288K
• X-ray data was collected at 100K in a nitrogen gas stream (dried paraffin oil) at 2.4 Angstrom resolution
• Multiwavelength anomalous dispersion (MAD) with zinc was used for phasing
![Page 44: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/44.jpg)
44
Source: Riboldi-Tunnicliffe, Alan et al., Nature Structural Biology, vol.8: 9. “Crystal structure of Mip, a prolylisomerase from Legionella pneumophila.” September 2001.
![Page 45: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/45.jpg)
Mechanism
• Peptidyl-prolyl cis-trans isomerases’ (PPIases) mechanism is not currently know
Source: Park, Steven T., et al. Journal of Biological Chemistry. Vol. 267 No.5, “PPIase Catalysis by Human Fk506-binding Protein Proceeds Through a Conformational Twist Mechanism.” February 1992.
![Page 46: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/46.jpg)
Source: Riboldi-Tunnicliffe, Alan et al., Nature Structural Biology, vol.8: 9. “Crystal structure of Mip, a prolylisomerase from Legionella pneumophila.” September 2001.
![Page 47: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/47.jpg)
![Page 48: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/48.jpg)
![Page 49: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/49.jpg)
49
![Page 50: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/50.jpg)
![Page 51: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/51.jpg)
51
![Page 52: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/52.jpg)
52
![Page 53: PRESENTATION II NAME By Christine Harvey Dihydrofolate Reductase Beta lactmase p300 Macrophage Infectivity Potentiator.](https://reader036.fdocuments.net/reader036/viewer/2022062717/56649e5e5503460f94b56e5b/html5/thumbnails/53.jpg)
53
Questions?